The Moses laser is a pulse-modulated holmium laser system designed to deliver energy more efficiently through water, and it has become one of the most talked-about advances in urological surgery over the past decade. Built on a standard holmium:YAG platform with an infrared wavelength of 2,120 nm, the technology splits each laser pulse into two phases: the first phase pushes water aside by creating a vapor bubble, and the second phase sends the remaining energy straight through that bubble to the target. The result is less wasted energy, less stone movement during kidney stone procedures, and better tissue cutting during prostate surgery. But whether it represents a must-have upgrade or a modest refinement depends on what you are using it for.
How the Moses Effect Works
Every holmium laser used in urology fires pulses of infrared light that water absorbs intensely. Because urological procedures happen in a fluid environment, a significant chunk of each pulse gets absorbed by the water sitting between the fiber tip and the stone or tissue. That absorption creates a vapor bubble, and only the energy that makes it through that bubble actually reaches the target. The bubble itself is not new; surgeons have been dealing with this inefficiency since holmium lasers entered urology in the 1990s. The phenomenon was first described back in 1986 in a cardiovascular application and was named the “Moses effect,” a nod to the biblical parting of the Red Sea.
What Moses technology does differently is deliberately exploit this bubble. Instead of firing one continuous pulse, the system converts each pulse into two sequential bursts. The first burst is tuned to create the vapor channel through the water. The second burst then travels through that already-cleared path, arriving at the stone or tissue with less energy lost along the way. The timing, energy split, and duration of each sub-pulse matter. Lab work using ultra-high-speed cameras has shown that a longer first pulse with lower energy produces the best stone fragmentation and the least stone movement, with retropulsion as low as about 0.28 mm under optimal settings.
Kidney Stone Treatment
Stone retropulsion has long been one of the frustrations of laser lithotripsy. You fire the laser at a stone, and the stone scoots away. This wastes time, makes the procedure harder, and can push fragments into difficult-to-reach areas of the kidney. Preclinical testing showed that both Moses modes (labeled A and B on the Lumenis system) produced significantly less stone displacement and higher ablation volumes compared to the standard firing mode.
A double-blinded randomized clinical trial confirmed these lab findings in actual patients. Surgeons grading retropulsion on a standardized scale found that the Moses mode cut stone movement roughly in half compared to the regular mode. The reduced retropulsion also translated into faster fragmentation times, because the surgeon spent less time chasing stones around the kidney.
A three-year prospective study from a university teaching hospital using a 60-watt Moses laser reported that roughly 94% of patients were stone-free after a single procedure, with a median operative time of 44 minutes. Those are strong numbers, though it is worth noting that stone-free rates depend heavily on stone size, location, and composition, not just the laser platform. Still, the combination of less retropulsion and efficient fragmentation appears to give Moses a practical edge in day-to-day stone surgery.
When it comes to the fine details of how you fire the laser, the settings matter as much as the technology itself. An experimental study testing different energy and pulse combinations found that high-power, high-energy settings with the Moses Distance mode produced the most effective ablation across different stone types. Under dusting settings with high frequency and low energy, the laser created deeper single cavitations rather than scattering small ones across the surface. The practical takeaway is that Moses technology gives surgeons more flexibility in how they approach a stone, but the surgeon still needs to match settings to the clinical situation.
Fiber Tip Durability
A detail that matters more to the surgeon than the patient, but ultimately affects both cost and safety, is what happens to the laser fiber during a procedure. Standard holmium fibers degrade at the tip as energy passes through them, a process called burnback. The fiber shortens and its tip quality deteriorates, sometimes requiring the surgeon to stop mid-procedure to strip and re-prepare the fiber.
A direct comparison of Moses fibers versus standard fibers during prostate enucleation found dramatically less degradation with the Moses system. Standard fibers lost a median of 2.9 cm, while Moses fibers lost just 0.2 cm. That difference held up whether the researchers measured degradation per unit of energy used, per minute of enucleation, or per gram of tissue removed. None of the cases using the Moses fiber required an intraoperative interruption to re-strip the fiber. Microscopic analysis confirmed the visible findings: the standard fibers showed substantially more structural damage.
An in vitro study looking specifically at stone dusting also found less fiber tip burnback with the Moses Contact and Moses Distance modes compared to the standard short-pulse mode. The Moses modes averaged about 0.28 to 0.29 mm of burnback versus 0.83 mm for standard short-pulse firing. For a surgeon performing a long case on a large stone burden, that difference means fewer interruptions and more consistent laser performance throughout the procedure.
Prostate Surgery With Moses
Holmium laser enucleation of the prostate, or HoLEP, is one of the most effective surgical treatments for benign prostatic enlargement. The procedure uses the holmium laser to shell out the obstructing prostate tissue from inside, much like scooping out the flesh of an orange while leaving the rind. It is technically demanding, and bleeding during the procedure is one of the main challenges, because blood obscures the surgeon’s view and slows the operation.
Moses technology addresses this by delivering energy more efficiently to tissue, which improves both cutting precision and the ability to seal blood vessels (hemostasis). A systematic review and meta-analysis found that the Moses system increased the amount of laser energy reaching the target, which improved tissue ablation and hemostasis during enucleation, increased visibility, and made the procedure easier for surgeons to perform efficiently.
Individual trials back this up with specific numbers. One study comparing Moses HoLEP to standard HoLEP found faster mean hemostasis time with the Moses system: about 8.7 minutes versus 10.6 minutes. A randomized controlled trial found even more dramatic benefits when trainees performed the surgery, with Moses 2.0 cutting hemostasis laser time from 9 minutes down to about 4 minutes. Surgeons also rated the Moses system higher for incision sharpness, fiber control, tissue separation, visibility, and charring. A separate comparative study found that Moses-enabled enucleation was associated with a roughly 4-minute decrease in time to achieve hemostasis compared to standard HoLEP.
One randomized trial from a high-volume center found that Moses HoLEP showed trends toward faster enucleation (about 22.5 minutes versus a longer time with standard HoLEP) and higher enucleation efficiency (about 3.5 grams per minute), though these differences did not reach statistical significance in that particular study. The pattern across the literature is consistent: Moses technology’s clearest advantage in prostate surgery is better bleeding control rather than dramatically faster tissue removal.
Moses 1.0 Versus 2.0
The Moses platform has already gone through at least one significant upgrade. A study comparing outcomes between Moses 1.0 and Moses 2.0 in prostate enucleation found that hemostasis was about 33% faster with the newer version, dropping from a median of 15 minutes to 10 minutes. This difference held up even after adjusting for prostate size and whether patients were taking blood-thinning medications. However, enucleation efficiency itself was comparable between the two generations. The researchers concluded that the primary advantage of the 2.0 update lies in enhanced hemostatic performance rather than procedural speed, reinforcing the pattern that Moses technology’s biggest contribution to prostate surgery is bleeding control.
How Moses Compares to Thulium Fiber Laser
The thulium fiber laser is the other major technology competing for space in urology suites, and the head-to-head comparisons with Moses holmium are more nuanced than marketing materials from either camp suggest.
For kidney stones, the picture is mixed. A large propensity-matched analysis from an international registry compared Moses holmium to thulium fiber laser in over 2,000 patients undergoing flexible ureteroscopy. Operation times and lasing times were similar between the two. However, stone-free rates were higher with the thulium fiber laser (85% versus 56%), partly because thulium was used with a pure dusting technique much more often (26% versus 6% of cases), and the Moses group relied more heavily on basket extraction (89% versus 43%). More sepsis events occurred in the thulium group, though the absolute numbers were small. A single-center randomized trial found no significant differences between the two lasers in ureteroscope time, stone-free rates, or complication rates. And a retrospective analysis also found comparable efficiency, ablation speeds, and outcomes between the two, though Moses had a significantly shorter lasing time when dealing specifically with calcium phosphate stones.
For prostate enucleation, a randomized prospective study comparing Moses HoLEP to thulium fiber laser enucleation found that Moses had a shorter median enucleation time (50 versus 57.5 minutes) and higher enucleation efficiency (about 2.0 versus 1.5 grams per minute). The Moses group also had less postoperative bleeding: only about 8% of Moses patients had immediate postoperative hematuria compared to roughly 31% of thulium patients. By 12 months, however, functional outcomes between the two groups were comparable.
A histopathological study looking at coagulation depth in human prostate tissue found no significant difference between standard holmium, Moses, and thulium fiber laser at comparable power settings. All three produced similar tissue effects, which suggests that the clinical differences between these platforms come from pulse dynamics and energy delivery patterns rather than fundamentally different tissue interactions.
Thermal Safety During Stone Procedures
High-power lasers generate heat, and when you are firing a laser inside the confined space of a kidney calyx, thermal injury to the kidney lining is a legitimate concern. The threshold commonly cited for tissue damage is 43°C sustained over a period of time. A clinical study measuring temperatures inside the kidney during high-power Moses holmium lithotripsy found that with room-temperature irrigation (25°C) flowing at 30 or 60 mL per minute, the local temperature in the kidney calyx never reached 43°C during 60 seconds of continuous laser activation. However, when body-temperature irrigation (37°C) was used at the same flow rates, temperatures in the kidney approached or exceeded 43°C at higher power settings of 32 and 40 watts with lower irrigation flow.
The practical message is straightforward: adequate irrigation flow and cooler irrigation fluid provide an important safety buffer. Surgeons using high-power Moses settings for large stone burdens should be mindful of irrigation rates, and using room-temperature saline rather than warmed fluid adds a meaningful margin of thermal safety. This is not unique to Moses technology; any high-power holmium or thulium laser carries the same thermal considerations. But as laser power settings continue to climb, awareness of heat management becomes more important.
Cost Considerations
Moses-compatible laser systems and fibers cost more upfront than standard holmium platforms. The dedicated Moses fibers are more expensive than generic fibers, and the laser generators themselves carry a premium. So does the technology actually save money overall?
A cost comparison focused on HoLEP found that Moses-enabled procedures resulted in hospital cost savings of about $840 per initial surgical episode. When emergency department visits and readmissions were factored in, the savings narrowed to roughly $747 per case, though that broader figure did not quite reach statistical significance. The savings came from shorter operative times, less bleeding-related resource use, and shorter hospital stays. Whether those savings offset the higher equipment costs depends on case volume: a busy center performing hundreds of HoLEP procedures a year will recoup equipment costs faster than a lower-volume practice.
Pediatric Applications
Children with kidney stones present unique challenges. Their anatomy is smaller, their ureters are narrower, and the margin for error is tighter. High-power Moses laser lithotripsy using a “dusting and pop-dusting” technique has been evaluated in pediatric patients. A prospective study of 35 children (ages 1 to 16) undergoing ureteroscopy with high-power laser lithotripsy found an overall stone-free rate of 94% on follow-up ultrasound. No procedural complications were noted, and the mean hospital stay was under a day. While this is a single-center series and not a randomized comparison, the results suggest that high-power Moses lithotripsy can be applied safely and effectively in the pediatric population.
What the Technology Does Not Change
For all its advantages, the Moses laser does not eliminate the fundamental challenges of urological procedures. Stone-free rates still depend heavily on stone size, location, and the anatomy of the patient’s kidney. A surgeon’s experience and technique remain the dominant variables in outcomes for both stone surgery and HoLEP. The learning curve for HoLEP in particular is steep regardless of laser platform, and while Moses may flatten that curve somewhat by improving visibility and hemostasis during training cases, it does not replace the hundreds of cases needed to become proficient.
It is also worth keeping perspective on what the comparison data actually shows. Many of the studies comparing Moses to standard holmium report trends in favor of Moses that do not always reach statistical significance, particularly for primary endpoints like total operative time or stone-free rate. Where Moses most consistently delivers measurable improvements is in secondary outcomes: less retropulsion, faster hemostasis, less fiber degradation, and subjectively better surgical ergonomics. These add up to a genuinely better experience for the surgeon and probably a modestly better experience for the patient, but they do not represent a paradigm shift in what the surgery can achieve.
The comparison with thulium fiber laser further complicates the picture. In stone surgery, thulium may achieve higher stone-free rates in certain contexts, while Moses holmium may offer advantages in specific stone compositions and fewer infectious complications. In prostate surgery, Moses appears to have the edge in hemostasis and short-term recovery, but long-term functional results converge. Hospitals choosing between the two platforms are making a judgment call based on their case mix, their surgeons’ familiarity, and their budget, not selecting a clearly superior technology.
Irrigation Flow and Practical Setup
One aspect that gets less attention in marketing but matters in the operating room is how Moses technology interacts with irrigation and working conditions. The vapor bubble that makes Moses work also affects fluid dynamics around the fiber tip. When the bubble forms and collapses, it can temporarily alter visibility and create turbulence. Surgeons who are used to standard holmium sometimes describe a brief adjustment period when switching to Moses, particularly noticing the different feel of tissue interaction during enucleation.
Irrigation management becomes especially relevant during high-power lithotripsy in tight spaces like a lower-pole kidney calyx, where fluid exchange is limited. As the thermal safety data shows, maintaining adequate irrigation flow is not optional when using power settings above 30 watts. Some centers have adopted protocols specifying minimum flow rates and maximum continuous lasing times when using high-power Moses settings in confined renal anatomy. These protocols are not standardized across institutions, but the principle is consistent: the laser’s efficiency means more energy reaches the target, which also means more heat accumulates if irrigation is inadequate.